NASDAQ:FULC | Insider Transactions — Page 2 | Fulcrum Therapeutics, Inc.

FULC Insider Transactions — Page 2

151 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–151; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Cadavid DiegoSVP Clinical Development2020-06-05Sale451.0$20.18
Cadavid DiegoSVP Clinical Development2020-06-04Sale226.0$20.05
Gould Robert JSee Remarks2020-06-04Sale1,300.0$20.04
Gould Robert JSee Remarks2020-06-03Sale1,500.0$20.13
Cadavid DiegoSVP Clinical Development2020-06-03Sale338.0$20.18
Cadavid DiegoSVP Clinical Development2020-06-02Sale45.0$20.0
Gould Robert JSee Remarks2020-06-02Sale2,797.0$20.0
Gould Robert JSee Remarks2020-06-01Sale5.0$20.0
Cadavid DiegoSVP Clinical Development2020-05-29Sale200.0$20.04
Gould Robert JSee Remarks2020-05-29Sale1,390.0$20.08
Cadavid DiegoSVP Clinical Development2020-05-28Sale600.0$20.0
Gould Robert JSee Remarks2020-05-28Sale1,919.0$20.01
Wallace Owen B.Chief Scientific Officer2020-05-28Sale2,232.0$20.0
Wallace Owen B.Chief Scientific Officer2020-05-27Sale448.0$20.0
Wallace Owen B.Chief Scientific Officer2020-05-26Sale412.0$20.0
Gould Robert JSee Remarks2020-05-26Sale2,500.0$20.0
Cadavid DiegoSVP Clinical Development2020-05-12Sale1,860.0$18.0
Thomson Peter G.VP Finance & Accounting2020-05-11Sale7,500.0$16.0
Cadavid DiegoSVP Clinical Development2020-03-02Sale315.0$18.13
Cadavid DiegoSVP Clinical Development2020-03-02Sale1,828.0$17.26
Thomson Peter G.VP Finance & Accounting2020-02-24Sale250.0$18.61
Thomson Peter G.VP Finance & Accounting2020-02-24Sale2,102.0$17.43
Thomson Peter G.VP Finance & Accounting2020-02-24Sale2,648.0$16.18
Gould Robert JSee Remarks2020-02-19Sale2,500.0$20.0
Wallace Owen B.Chief Scientific Officer2020-02-19Sale6,088.0$20.0
Cadavid DiegoSVP Clinical Development2020-02-03Sale2,143.0$17.33
Thomson Peter G.VP Finance & Accounting2020-01-23Sale262.0$18.05
Thomson Peter G.VP Finance & Accounting2020-01-23Sale4,738.0$17.17
SanofiTenPercentOwner2019-07-22Purchase93,750.0$16.0
6 Dimensions Capital, L.P.TenPercentOwner2019-07-22Purchase118,750.0$16.0
Casdin Partners GP, LLCTenPercentOwner2019-07-22Purchase5,000.0$14.5
Casdin Capital, LLCTenPercentOwner2019-07-22Purchase5,000.0$14.5
Casdin EliTenPercentOwner2019-07-22Purchase5,000.0$14.5
Casdin Partners Master Fund, L.P.TenPercentOwner2019-07-22Purchase5,000.0$14.5
Casdin Partners GP, LLCTenPercentOwner2019-07-22Purchase10,000.0$14.5
Casdin Capital, LLCTenPercentOwner2019-07-22Purchase10,000.0$14.5
Casdin EliTenPercentOwner2019-07-22Purchase10,000.0$14.5
Casdin Partners Master Fund, L.P.TenPercentOwner2019-07-22Purchase10,000.0$14.5
Casdin Partners GP, LLCTenPercentOwner2019-07-22Purchase125,000.0$16.0
Casdin Capital, LLCTenPercentOwner2019-07-22Purchase125,000.0$16.0
Casdin EliTenPercentOwner2019-07-22Purchase125,000.0$16.0
Casdin Partners Master Fund, L.P.TenPercentOwner2019-07-22Purchase125,000.0$16.0
LEVIN MARK JDirector,TenPercentOwner2019-07-22Purchase81,250.0$16.0
TRV GP IV, LLCTenPercentOwner2019-07-22Purchase81,250.0$16.0
Third Rock Ventures GP IV, L.P.TenPercentOwner2019-07-22Purchase81,250.0$16.0
Third Rock Ventures IV, L.P.TenPercentOwner2019-07-22Purchase81,250.0$16.0
TEPPER ROBERT ITenPercentOwner2019-07-22Purchase81,250.0$16.0
STARR KEVIN PTenPercentOwner2019-07-22Purchase81,250.0$16.0
Third Rock Ventures III, L.P.TenPercentOwner2019-07-22Purchase81,250.0$16.0
TRV GP III, LLCTenPercentOwner2019-07-22Purchase81,250.0$16.0
Third Rock Ventures GP III, L.P.TenPercentOwner2019-07-22Purchase81,250.0$16.0